Donald A. Wuchterl - 08 Jul 2025 Form 4 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)

Role
Director
Signature
/s/ Donald A. Wuchterl
Issuer symbol
ABEO
Transactions as of
08 Jul 2025
Net transactions value
-$30,147
Form type
4
Filing time
10 Jul 2025, 16:30:35 UTC
Previous filing
03 Feb 2025
Next filing
27 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wuchterl Donald A. Director 6555 CARNEGIE AVE., 4TH FLOOR, CLEVELAND /s/ Donald A. Wuchterl 10 Jul 2025 0001857854

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABEO Common Stock Sale $30,147 -5,176 -3.4% $5.82 145,436 08 Jul 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.74 to $5.87 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.